Tweet
Oxaliplatin manufacturer is a platinum anticancer drug which is used to treat colorectal cancer, one of the most common types of cancer. It can be given alone or in combination with other drugs. It works by sticking to one of the DNA strands in the cancer cell. This stops it from being able to grow or reproduce. Oxaliplatin has also been shown to have a good effect on other cancers, such as lung cancer and breast cancer.
Ibrutinib manufacturer price is a first-of-its-kind irreversible inhibitor of Bruton's tyrosine kinase (BTK), which plays a critical role in the B-cell receptor (BCR) signaling pathway that is involved in normal and malignant B-cell development. Ibrutinib has been shown to improve survival in hematological malignancies, including chronic lymphocytic leukemia/small lymphocytic leukemia, mantle cell lymphoma and Waldenstrom macroglobulinemia and is currently approved by the U.S. FDA and China FDA for use in patients with previously untreated CLL/SLL, MCL, marginal zone lymphoma or Waldenstrom macroglobulinemia.
Ibrutinib manufacturer price is a first-of-its-kind irreversible inhibitor of Bruton's tyrosine kinase (BTK), which plays a critical role in the B-cell receptor (BCR) signaling pathway that is involved in normal and malignant B-cell development. Ibrutinib has been shown to improve survival in hematological malignancies, including chronic lymphocytic leukemia/small lymphocytic leukemia, mantle cell lymphoma and Waldenstrom macroglobulinemia and is currently approved by the U.S. FDA and China FDA for use in patients with previously untreated CLL/SLL, MCL, marginal zone lymphoma or Waldenstrom macroglobulinemia.